- Home
- YCBD vs SPRC Comparison
YCBD vs SPRC Comparison
Compare YCBD & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YCBD
- SPRC
- Stock Information
- Founded
- YCBD 2015
- SPRC 2004
- Country
- YCBD United States
- SPRC Israel
- Employees
- YCBD N/A
- SPRC N/A
- Industry
- YCBD Biotechnology: Pharmaceutical Preparations
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- YCBD Health Care
- SPRC Health Care
- Exchange
- YCBD Nasdaq
- SPRC Nasdaq
- Market Cap
- YCBD 4.5M
- SPRC 4.0M
- IPO Year
- YCBD N/A
- SPRC N/A
- Fundamental
- Price
- YCBD $0.51
- SPRC $2.55
- Analyst Decision
- YCBD Strong Buy
- SPRC
- Analyst Count
- YCBD 1
- SPRC 0
- Target Price
- YCBD $2.00
- SPRC N/A
- AVG Volume (30 Days)
- YCBD 161.6K
- SPRC 34.5K
- Earning Date
- YCBD 12-17-2025
- SPRC 01-01-0001
- Dividend Yield
- YCBD N/A
- SPRC N/A
- EPS Growth
- YCBD N/A
- SPRC N/A
- EPS
- YCBD N/A
- SPRC N/A
- Revenue
- YCBD $19,026,064.00
- SPRC $1,306,000.00
- Revenue This Year
- YCBD $0.37
- SPRC N/A
- Revenue Next Year
- YCBD $4.95
- SPRC N/A
- P/E Ratio
- YCBD N/A
- SPRC N/A
- Revenue Growth
- YCBD N/A
- SPRC N/A
- 52 Week Low
- YCBD $0.47
- SPRC $1.75
- 52 Week High
- YCBD $6.54
- SPRC $37.59
- Technical
- Relative Strength Index (RSI)
- YCBD 26.99
- SPRC 39.81
- Support Level
- YCBD $0.48
- SPRC $2.23
- Resistance Level
- YCBD $0.83
- SPRC $2.61
- Average True Range (ATR)
- YCBD 0.07
- SPRC 0.20
- MACD
- YCBD -0.02
- SPRC 0.01
- Stochastic Oscillator
- YCBD 9.92
- SPRC 33.42
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.